Serra Raffaele, de Franciscis Stefano, Grande Raffaele, Butrico Lucia, Perri Paolo, Indolfi Ciro, Mastroroberto Pasquale
Interuniversity Center of Phlebolymphology (CIFL). International Research and Educational Program in Clinical and Experimental Biotechnology. Headquarters: University Magna Graecia of Catanzaro, Viale Europa, Catanzaro, 88100, Italy.
Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Viale Europa, Catanzaro, Germaneto, 88100, Italy.
J Cardiothorac Surg. 2015 Nov 21;10:171. doi: 10.1186/s13019-015-0388-5.
Most blunt aortic injuries occur in the proximal proximal descending aorta causing acute transection of this vessel. Generally, surgical repair of the ruptured segment of aorta is associated with high rates of morbidity and mortality and in this view endovascular treatment seems to be a valid and safer alternative. Aim of this article is to review our experience with endovascular approach for the treatment of acute traumatic rupture of descending thoracic aorta.
From April 2002 to November 2014, 11 patients (9 males and 2 females) were referred to our Department with a diagnosis of acute transection of thoracic aorta. Following preoperative Computed Tomography (CT) evaluation, thoracic endovascular aortic repair (TEVAR) with left subclavian artery coverage was performed. Follow-up consisted clinical and instrumental (CT, Duplex ultrasound) controls at discharge, 1, 3 and 6 months and yearly thereafter.
At 12-year follow up, the overall survival for the entire patients cohort was 100 %, no major or minor neurological complications and no episode of left arm claudication occurred. Cardiovascular, respiratory and bleeding complications, in the early period, was represented by minor, non fatal events. No stent graft failure, collapse, leak or distal migration were detected at CT scan during the entire follow up period.
According to our experience, despite the small number of patient population, TEVAR procedure with with left subclavian artery coverage, performed in emergency settings, seems to provide excellent long term results.
The protocol was registered at a public trials registry, www.clinicaltrials.gov (trial identifier NCT02376998 ).
大多数钝性主动脉损伤发生在降主动脉近端,导致该血管急性横断。一般来说,对破裂的主动脉段进行手术修复的发病率和死亡率较高,从这个角度来看,血管内治疗似乎是一种有效且更安全的选择。本文的目的是回顾我们采用血管内方法治疗胸降主动脉急性创伤性破裂的经验。
2002年4月至2014年11月,11例患者(9例男性,2例女性)因胸主动脉急性横断诊断被转诊至我院。术前进行计算机断层扫描(CT)评估后,实施了覆盖左锁骨下动脉的胸主动脉腔内修复术(TEVAR)。随访包括出院时、术后1个月、3个月和6个月以及此后每年的临床和器械(CT、双功超声)检查。
在12年的随访中,整个患者队列的总生存率为100%,未发生重大或轻微神经系统并发症,也未出现左臂间歇性跛行发作。早期的心血管、呼吸和出血并发症均为轻微的非致命事件。在整个随访期间,CT扫描未检测到支架移植物失败、塌陷、渗漏或远端移位。
根据我们的经验,尽管患者数量较少,但在紧急情况下实施的覆盖左锁骨下动脉的TEVAR手术似乎能提供出色的长期效果。
该方案已在公共试验注册库www.clinicaltrials.gov注册(试验标识符NCT02376998)。